These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8329834)

  • 1. Growth in children with X-linked hypophosphataemic rickets.
    Verge CF; Cowell CT; Howard NJ; Donaghue KC; Silink M
    Acta Paediatr Suppl; 1993 Mar; 388():70-5; discussion 76. PubMed ID: 8329834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of therapy in X-linked hypophosphatemic rickets.
    Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M
    N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypophosphataemic rickets: final height and clinical symptoms in adults.
    Stickler GB; Morgenstern BZ
    Lancet; 1989 Oct; 2(8668):902-5. PubMed ID: 2571821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Growth hormone treatment of familial hypophosphatemic rickets].
    Saggese G; Baroncelli GI; Barsanti S
    Arch Pediatr; 1998; 5 Suppl 4():360S-363S. PubMed ID: 9853084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of phosphate supplementation on linear growth in children with X-linked hypophosphatemia.
    Seikaly MG; Browne RH; Baum M
    Pediatrics; 1994 Oct; 94(4 Pt 1):478-81. PubMed ID: 7936855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth in X-linked hypophosphatemic rickets.
    Ariceta G; Langman CB
    Eur J Pediatr; 2007 Apr; 166(4):303-9. PubMed ID: 17171343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early treatment of familial hypophosphataemic rickets.
    Roza M; Miguel MA; Galbe M; Mejido L; Mencia C
    Arch Dis Child; 1983 Dec; 58(12):1020-2. PubMed ID: 6689262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence suggesting hyperoxaluria as a cause of nephrocalcinosis in phosphate-treated hypophosphataemic rickets.
    Reusz GS; Latta K; Hoyer PF; Byrd DJ; Ehrich JH; Brodehl J
    Lancet; 1990 May; 335(8700):1240-3. PubMed ID: 1971321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium metabolism and growth during early treatment of children with X-linked hypophosphataemic rickets.
    Kruse K; Hinkel GK; Griefahn B
    Eur J Pediatr; 1998 Nov; 157(11):894-900. PubMed ID: 9835432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effect of conventional phosphate and calcitriol treatment on metabolic recovery and catch-up growth in children with PHEX mutation.
    Alikasifoglu A; Unsal Y; Gonc EN; Ozon ZA; Kandemir N; Alikasifoglu M
    J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1573-1584. PubMed ID: 34525271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-linked hypophosphatemia. Genetic and clinical correlates.
    Hanna JD; Niimi K; Chan JC
    Am J Dis Child; 1991 Aug; 145(8):865-70. PubMed ID: 1858722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of GH replacement therapy in two male siblings with combined X-linked hypophosphatemia and partial GH deficiency.
    Schütt SM; Schumacher M; Holterhus PM; Felgenhauer S; Hiort O
    Eur J Endocrinol; 2003 Oct; 149(4):317-21. PubMed ID: 14514346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth and bone mineral density in a child with X-linked hypophosphatemic rickets: early response to treatment.
    Sugiyama T; Tanaka H; Kawai S
    J Bone Miner Metab; 1999; 17(2):137-40. PubMed ID: 10340642
    [No Abstract]   [Full Text] [Related]  

  • 14. A trial of growth hormone therapy in well-controlled hypophosphataemic rickets.
    Cameron FJ; Sochett EB; Daneman A; Kooh SW
    Clin Endocrinol (Oxf); 1999 May; 50(5):577-82. PubMed ID: 10468922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial hypophosphataemic rickets: experience with 24 children from Kuwait.
    Lubani MM; Khuffash FA; Reavey PC; Sharda DC; Alshab TS
    Ann Trop Paediatr; 1990; 10(4):377-81. PubMed ID: 1708966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone therapy in hypophosphatemic rickets.
    Wilson DM; Lee PD; Morris AH; Reiter EO; Gertner JM; Marcus R; Quarmby VE; Rosenfeld RG
    Am J Dis Child; 1991 Oct; 145(10):1165-70. PubMed ID: 1928011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypophosphataemic rickets and final height.
    Lancet; 1990 Mar; 335(8688):536-7. PubMed ID: 1968543
    [No Abstract]   [Full Text] [Related]  

  • 18. Spontaneous Growth and Effect of Early Therapy with Calcitriol and Phosphate in X-linked Hypophosphatemic Rickets.
    Cagnoli M; Richter R; Böhm P; Knye K; Empting S; Mohnike K
    Pediatr Endocrinol Rev; 2017 Nov; 15(Suppl 1):119-122. PubMed ID: 29292875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrocalcinosis in X-linked hypophosphataemic rickets: its relationship to treatment, kidney function, and growth.
    Kooh SW; Binet A; Daneman A
    Clin Invest Med; 1994 Apr; 17(2):123-30. PubMed ID: 8004848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR).
    Rothenbuhler A; Esterle L; Gueorguieva I; Salles JP; Mignot B; Colle M; Linglart A
    Growth Horm IGF Res; 2017 Oct; 36():11-15. PubMed ID: 28822957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.